Among critically ill patients with COVID-19, serum IL-6 and IL-10 levels are usually higher, while serum GM-CSF, TNF- α, IFN-γ, IL-2 and IL-8 serve as ancillary cytokines with clinical prognostic value in contrast to patients without critical disease [14,30,31]. This evidence concerns the gene IL2 and COVID-19.